Safety, Tolerability and Preliminary Efficacy of JK1201I in Patients With SCLC
Status:
Recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to evaluate the safety, tolerability and primary
efficacy of JK-1201I in patients with small cell lung cancer (SCLC)